B细胞急性淋巴细胞白血病肿瘤微环境中单核-巨噬细胞极化与募集通路
该研究探讨B-ALL骨髓微环境中单核/巨噬细胞区室及募集通路的变化。免疫组化显示白血病骨髓中CD68+巨噬细胞增多且以M2样CD163/CD206为主,外周血非经典CD14+CD16++单核细胞增加,骨髓血浆CX3CL1、CCL2和C5a上调,提示单核/巨噬细胞失调参与微环境重塑并可能成为治疗靶点。
要点
- B-ALL骨髓中CD68+巨噬细胞增多且以M2样CD163/CD206表型为主
- 外周血非经典CD14+CD16++单核细胞亚群显著增加且CX3CR1高表达
- 骨髓血浆CX3CL1、CCL2和C5a上调,可能驱动单核细胞募集与M2极化
核心结论
- B-ALL诊断时骨髓微环境存在单核/巨噬细胞区室失调,可能成为与经典化疗联合的新治疗靶点。
研究设计与样本
- 研究采用免疫组化分析白血病骨髓活检中巨噬细胞标志物,并检测外周血单核细胞亚群及骨髓血浆中趋化因子和补体因子水平。
主要发现
- 免疫组化显示白血病骨髓活检中CD68表达巨噬细胞较对照增多,且主要表达M2样标志物CD163和CD206。
- B-ALL患者外周血中表达高水平CX3CR1的非经典CD14+CD16++单核细胞亚群显著增加。
- 白血病骨髓血浆中CX3CL1显著上调,可能改变迁移通路引导非经典单核细胞募集至骨髓。
- 白血病骨髓血浆中单核/巨噬细胞趋化因子CCL2强烈增加,可能与白血病细胞与间充质基质细胞和血管细胞相互作用及白血病相关炎症介质刺激有关。
- C5a在白血病骨髓中上调,可能继发于PTX3降低所释放的补体级联激活。
临床怎么用
- B-ALL诊断时需关注骨髓微环境中M2样巨噬细胞增多及非经典单核细胞亚群增加,这些可能作为潜在治疗靶点。
- CX3CL1、CCL2和C5a等通路可能为联合经典化疗的新干预策略提供方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
B-cell acute lymphoblastic leukaemia (B-ALL) reprograms the surrounding bone marrow (BM) stroma to create a leukaemia-supportive niche. To elucidate the contribution of immune cells to the leukaemic microenvironment, we investigated the involvement of monocyte/macrophage compartments, as well as several recruitment pathways in B-ALL development. Immunohistochemistry analyses showed that CD68-expressing macrophages were increased in leukaemic BM biopsies, compared to controls and predominantly expressed the M2-like markers CD163 and CD206. Furthermore, the "non-classical" CD14+ CD16++ monocyte subset, expressing high CX3CR1 levels, was significantly increased in B-ALL patients' peripheral blood. CX3CL1 was shown to be significantly upregulated in leukaemic BM plasma, thus providing an altered migratory pathway possibly guiding NC monocyte recruitment into the BM. Additionally, the monocyte/macrophage chemoattractant chemokine ligand 2 (CCL2) strongly increased in leukaemic BM plasma, possibly because of the interaction of leukaemic cells with mesenchymal stromal cells and vascular cells and due to a stimulatory effect of leukaemia-related inflammatory mediators. C5a, a macrophage chemoattractant and M2-polarizing factor, further appeared to be upregulated in the leukaemic BM, possibly as an effect of PTX3 decrease, that could unleash complement cascade activation. Overall, deregulated monocyte/macrophage compartments are part of the extensive BM microenvironment remodelling at B-ALL diagnosis and could represent valuable targets for novel treatments to be coupled with classical chemotherapy.
引用
- Dander E, Fallati A, Gulić T, et al. Monocyte-macrophage polarization and recruitment pathways in the tumour microenvironment of B-cell acute lymphoblastic leukaemia. Br J Haematol. 2021. PMID: 33713428. doi:10.1111/bjh.17330
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。